Pneumeric, Inc. has partnered with JP Pharma to distribute the Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. The device provides quick visual confirmation of needle placement, assisting emergency responders in life-saving procedures. Both companies aim to elevate medical care standards through this collaboration.
Pneumeric, Inc. has formalized a distribution agreement with JP Pharma, a major South American tactical medical supplier, to introduce its Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. This innovative device offers visual confirmation of proper needle placement through a color change, enhancing the efficiency of emergency responders who can then administer critical treatments more swiftly.
JP Pharma, known for representing top international medical manufacturers, aims to elevate standards in Brazil’s medical market. The inclusion of Capnospot® aligns with both companies’ commitment to innovation and improved patient outcomes in emergency medical care.
Bruno Tavora, Chief Operating Officer of JP Pharma, expressed enthusiasm about the partnership, emphasizing the shared dedication to enhancing pre-hospital care in Brazil. He is optimistic about the potential of Capnospot® to save lives. Deon Miller, Chief Commercial Officer of Pneumeric, Inc., also expressed confidence in the mutual benefits of this collaboration for both companies.
Capnospot® is designed to augment the precision of tension pneumothorax decompression, offering immediate visual feedback on successful decompression, which is crucial for first responders in emergency situations.
Founded in 2021, Pneumeric, Inc. focuses on advancing tension pneumothorax care, having received FDA clearance in 2023 and securing two patents for Capnospot®. JP Pharma, established in 2008, aims to provide Brazil with superior medical devices through strategic collaborations. Further information about both organizations can be accessed via their respective websites.
The partnership between Pneumeric, Inc. and JP Pharma marks a significant advancement in Brazil’s emergency medical response capabilities through the introduction of the Capnospot® device. This collaboration not only illustrates a commitment to innovation but also highlights the potential for improved patient outcomes in critical situations. The efforts of both companies aim to enhance the standards of pre-hospital care and ultimately save lives in Brazil.
Original Source: www.prweb.com
